Diabetes and SGLT2-iss inhibitors in patients with heart failure with preserved or mid-range left ventricular ejection fractions
Andrea Passantino, Caterina Rizzo, Domenico Scrutinio, Alberto Palazzuoli
Topics & Concepts
MedicineCardiologyInternal medicineHeart failureHeart failure with preserved ejection fractionDiabetes mellitusDiabetic cardiomyopathyBlood pressureArterial stiffnessGlycationEjection fractionCardiomyopathyEndocrinologyDiabetes Treatment and ManagementCardiovascular Function and Risk FactorsPancreatic function and diabetes